Velsera is a precision medicine technology company that provides AI-enhanced software platforms and expert services to accelerate the discovery, development, and delivery of precision medicine solutions. It serves biotech, pharma, clinical diagnostic labs, NGS manufacturers, and non-profits by enabling multi-omic data analysis, harmonization, and clinical reporting. Formed in 2023 from Seven Bridges, Pierian, and UgenTec, it operates as an established scale-up in the omics analytics market.